59
Participants
Start Date
June 14, 2020
Primary Completion Date
May 31, 2022
Study Completion Date
June 30, 2022
IL-2
For all patients,rhIL-2 infusions seven days;recurrent patients was applied again for 7 days;patients who were diagnosed HSPN were treated on a routine basis for 7 consecutive days, and then once every two week for 3months.
Sirui Yang, Changchun
The First Hospital of Jilin University
OTHER